Safety, Reactogenicity and Immunogenicity of an H5N1 VLP

Clinical trial NCT00519389 · COMPLETED

Trial details

NCT number: NCT00519389
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pandemic Influenza

Start date: 2007-07-01
Primary completion: 2008-11-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.